Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers

Japanese Journal of Cancer Research

Volumn 90, Issue 12, 1999, Pages 1338-1373

  Ochiai, Mari ^a   Oguri, Tetsuya ^a   Isobe, Takeshi ^a   Ishioka, Shinichi ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclooxygenase 2 (COX 2); Non small cell lung cancer; RT PCR

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA;

ADENOSARCOMA; ADULT; AGED; ARTICLE; AUTOPSY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MALE; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

EID: 0033391889     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00717.x     Document Type: Article

References (29)

1. Vane, J. R., Bakhle, Y. S. and Botting, R. M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol., 38, 97-120 (1998).
2. Thun, M. J., Mohan, M., Namboodiri, B. S. and Heath, C. W. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 3258, 1593-1596 (1991).
3. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Brooker, S. V., Robinson, C. R. and Offerhaus, G. J. A. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316 (1993).
4. △716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell, 87, 803-809 (1996).
5. Reddy, B. S., Rao, C. V. and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56, 4566-4569 (1996).
6. Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D. and DuBois, R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99, 2254-2259 (1997).
7. Kawamori, T., Rao, C. V., Seibert, K. and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412 (1998).
8. Sano, H., Kuwahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789 (1995).
9. Ristimaki, A., Honkanen, N., Jankala, H., Sipponen, P. and Harkonen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57, 1276-1280 (1997).
10. Hwang, D., Scollard, D., Byrne, J. and Levine, E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Natl. Cancer Inst., 90, 455-460 (1998).
11. Oguri, T., Fujiwara, Y., Isobe, T., Katoh, O., Watanabe, H. and Yamakido, M. Expression of γ-glutamylcysteine synthetase (γ-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs. Br. J. Cancer, 77, 1089-1096 (1988).
12. Hida, T., Leyton, J., Makheja, A. M., Ben-Av, P., Hle, T., Martinez, A., Mulshine, J., Malkani, S., Dhung, P. and Moody, T. W. Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. Anticancer Res., 18, 775-782 (1998).
13. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T. and Takahashi, T. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58, 3761-3764 (1998).
14. Wolff, H., Saukkonen, K., Antilla, S., Karjalainen, A., Vainio, H. and Ristimaki, A. Expression of cyclooxygen ase-2 in human lung carcinoma. Cancer Res., 58, 4997-5001 (1998).
15. Rioux, N. and Castonguay, A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res., 58, 5354-5360 (1998).
16. Zimmermann, K. C., Sarbia, M., Weber, A. A., Brochard, F., Gabbert, H. E. and Schror, K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res., 59, 198-204 (1999).
17. Chan, G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G. M., Masferrer, J. L. and Dannenberg, A. J. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59, 991-994 (1999).
18. Sobue, T., Suzuki, T., Fujimoto, I., Doi, O., Tateishi, R. and Sato, T. Prognostic factors for surgically treated lung adenocarcinomas patients, with special reference to smoking habit. Jpn. J. Cancer Res., 82, 33-39 (1991).
19. Stenbygaard, L. E., Sorensen, J. B. and Olsen, J. E. Metastatic pattern in adenocarcinoma of the lung. An autopsy study from a cohort of 137 consecutive patients with complete resection. J. Thorac. Cardiovasc. Surg., 110, 1130-1135 (1995).
20. Nakayama, Y., Hayakawa, K., Mitsuhashi, N., Saito, Y. and Niibe, H. Long-term survivors of non-small cell lung cancer after radiation therapy: the significance of histological type. Anticancer Res., 17, 2769-2773 (1997).
21. Achiwa, H., Yatabe, Y., Hida, T., Kuroishi, T., Kozaki, K., Nakamura, S., Ogawa, M., Sugiura, T., Mitsudomi, T. and Takahashi, T. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin. Cancer Res., 5, 1001-1005 (1999).
22. Tsujii, M., Kawano, S. and DuBois, R. N. Cyclooxygenase-2 expression in human colorectal cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA, 94, 3336-3340 (1997).
23. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M. and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716 (1998).
24. Bikfalvi, A. Significance of angiogenesis in tumour progression and metastasis. Eur. J. Cancer, 31A, 1101-1104 (1995).
25. Kumar, R. and Fidler, I. J. Angiogenic molecules and cancer metastasis. In Vivo, 12, 27-34 (1998).
26. Kleiner, D. E., Emmert-Buck, M. R. and Liotta, L. A. Necropsy as a research method in the age of molecular pathology. Lancet, 346, 945-948 (1995).
27. Elder, D. J. E., Halton, D. E., Hague, A. and Paraskevaka, C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin. Cancer Res., 3, 1679-1683 (1997).
28. Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D. and DuBois, R. N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res., 58, 362-366 (1998).
29. Liu, H. X., Yao, S., Kirschenbaum, A. and Levine, A. C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res., 58, 4245-4249 (1998).